In particular, low SHBG serum levels have been associated with high levels of markers of inflammation [19], and with the risk of onset and progression of obesity, NAFLD and metabolic syndrome (MetS) [20]. Here, SHBG is linked to metabolic dysfunction-associated steatotic liver disease.